Friday, November 8, 2024
HomeFunding ZBiotics Raises $12 Million in Series A Funding

[Funding News] ZBiotics Raises $12 Million in Series A Funding

ZBiotics, the pioneers carving a new category of genetically engineered probiotics, has raised $12 million in Series A funding round led by Spring Tide Capital with participation by Access Capital, Seamless Capital, Goat Rodeo Capital, and Seaside Ventures.

ZBiotics, the pioneers carving a new category of genetically engineered probiotics, has raised $12 million in Series A funding round led by Spring Tide Capital with participation by Access Capital, Seamless Capital, Goat Rodeo Capital, and Seaside Ventures.

Read also – [Funding News] Supio Raises $25 Million in Series A Funding

The company intends to utilise the funds to cater to the increasing demands of its clientele, lead the way in expanding its retail presence, and promote ongoing research and development in an entirely new industry. This will involve the introduction of novel genetically modified probiotic products that tackle the distinct and emerging biological obstacles of contemporary life.

Read also – Swiftly Acquires Hopthru
 
“Genetic engineering allows us to make totally new products that address real-world consumer needs, and we’re witnessing a growing interest in our technology and brand,” stated Zack Abbott, Ph.D., co-founder and CEO of ZBiotics. “In a market that craves real solutions, we’ve shown that being a proudly GMO company prioritizing transparency resonates with consumers, driving ZBiotics’ momentum. With these funds, we aim to meet demand and expand the ZBiotics product line beyond our flagship product.”

“Off of the breakout success of their first product, ZBiotics has more than doubled sales every year, selling over 5 million units cumulatively and reaching company-wide profitability in 2023,” said Adam Ramada, co-managing partner of Spring Tide Capital. “We are thrilled to support the team as they continue to expand their revolutionary probiotic platform across many more exciting use cases that address everyday consumer pain points.”

Using the same technology that was used to create its pre-alcoholic probiotic drink, ZBiotics will use the money from its Series A round to develop and market other use-case probiotics. These products will help consumers who are trying to prioritise different elements of their health. The company will introduce its second product, which will highlight the benefits of gut bacteria variety, in the coming weeks in addition to its flagship offering.

ZBiotics’ research and development team is currently investigating several items that could potentially benefit athletes, improve vaginal health, and improve sleep. The company will also use the money to launch the ZBiotics brand in physical stores, aligning with its long-term objective of manufacturing ‘proudly GMO’ products.

About ZBiotics

Founded in 2016, Zack Abbott, PhD microbiologist, founded ZBiotics because of the potential genetically engineered probiotics have to improve daily living. Our first product is a probiotic that helps you feel better the day after drinking alcohol. ZBiotics is leveraging its patented technology to create a whole new category of products that help our bodies deal with whatever modern life throws our way.

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular